Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.eururo.2025.01.024 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Increasing Life Expectancy in Patients with Genitourinary Malignancies: Impact of Treatment Burden on Disease Management and Quality of Life.
Eur Urol
December 2024
Department of Urology, University of Washington, Seattle, WA, USA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. Electronic address:
Background And Objective: Treatment burden refers to the overall impact of medical treatments on a patient's well-being and daily life. Our objective is to evaluate the impact of treatment burden on quality of life (QoL) in patients with genitourinary (GU) malignancies, highlighting the importance of patient-reported outcomes (PROs) in clinical trials to inform treatment decisions and improve patient care.
Methods: We conducted a narrative review of clinical trials focused on GU malignancy (prostate, bladder, and kidney) between January 2000 and June 2024, analyzing related PROs and findings regarding treatment burden.
Can a Molecular Classifier of Upper Tract Urothelial Carcinoma Inform Clinical Decision-making and Biological Stratification?
Eur Urol
March 2025
Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
Navigating prostate cancer screening in Canada for marginalized men through PSA screening and guidelines adherence A call to action for policymakers.
Can Urol Assoc J
September 2024
Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Reply by Author.
J Urol
July 2024
Department of Radiation Oncology, British Columbia Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada.
Re: FGFR Inhibition Augments Anti-PD-1 Efficacy in Murine FGFR3-mutant Bladder Cancer by Abrogating Immunosuppression.
Eur Urol
August 2024
Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!